Regulus Therapeutics Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Regulus Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • Regulus Therapeutics Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.17 USD/shares, a 54.1% increase year-over-year.
  • Regulus Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was 1.91 USD/shares, a 5.91% decline year-over-year.
  • Regulus Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was 1.58 USD/shares, a 15.1% decline from 2022.
  • Regulus Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was 1.86 USD/shares, a 42.6% decline from 2021.
  • Regulus Therapeutics Inc. annual Earnings Per Share, Basic for 2021 was 3.24 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.58 $0 -15.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $1.86 -$1 -42.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $3.24 +$3.69 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.